Glamorous AI announce a collaboration with Cardiff University on Covid-19 inhibitors

Glamorous AI forms a partnership with Cardiff University to discover possible Covid-19 drugs UK-based Artificial intelligence (AI) drug discovery company Glamorous AI has announced that it has entered into a research collaboration with Cardiff University focusing on the use of Glamorous AI’s platform for Covid-19 research. The partners will collaborate to discover novel inhibitors against […]

Read more
Rosalind’s computational docking available for Covid-19 researchers

Molecular docking can be an important step in analysing compound designs, filtering through huge chemical spaces and prioritising promising compounds. In our Covid-19 project (check it out here and read the paper here), docking and binding energy calculations are a big part of Rosalind’s prioritisation phase.  We know setting up a docking process for the scale necessary […]

Read more